Focus on Biosimilars: Oncology Nurses Identify Knowledge Gaps and Brainstorm Concepts for Education

The first biosimilar was approved by the FDA in 2015 and ever since they have been transforming oncology treatment by decreasing cost, offering additional treatment possibilities, and improving access to medications for patients. This resource will help the nurse achieve a higher understanding of biosimilar therapy, why they are used, and when they are used. This resource provides easy to understand analogies and strategies on how to educate your patients on biosimilars.